OxyContin Maker Purdue Pharma to Plead to Three Criminal Charges

Purdue Pharma, the company that makes OxyContin, the powerful prescription painkiller that experts say helped touch off an opioid epidemic, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion, Justice Department officials announced Wednesday.

The company will plead guilty to three counts, including conspiracy to defraud the United States and violating federal anti-kickback laws, the officials said. The resolution will be detailed in a bankruptcy court filing in federal court.

Read More

Experts: Revamped OxyContin Hasn’t Curbed Abuse, Overdoses

A panel of government health advisers said Friday there’s no clear evidence that a harder-to-crush version of the painkiller OxyContin designed to discourage abuse actually resulted in fewer overdoses or deaths.

The conclusion from the Food and Drug Administration advisory panel comes more than a decade after Purdue Pharma revamped its blockbuster opioid, which has long been blamed for sparking a surge in painkiller abuse beginning in the 1990s.

Read More

Maker of OxyContin Agrees to $270M Settlement in Oklahoma

The maker of OxyContin and the company’s controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create the nation’s deadly opioid crisis with their aggressive marketing of the powerful painkiller. It is the first settlement to come out of the recent coast-to-coast…

Read More

New Info About Opioid-Profiteering Family Pushes Largest Museum in US to Rethink Gift Acceptance Policies

by Evie Fordham   The Metropolitan Museum of Art is reviewing its gift acceptance policies after information that members of a prominent donor family headed a deceit campaign to push the highly addictive prescription opioid OxyContin, The Met told The Daily Caller News Foundation. Other New York City art museums…

Read More